Update shared on 02 Dec 2025
Fair value Decreased 0.45%Analysts have slightly reduced their price target for Energean from $9.85 to $9.81. This adjustment reflects expectations for higher revenue growth and improved profit margins, partially offset by a modestly higher discount rate and lower future price-to-earnings estimates.
What's in the News
- Energean reported average production of 151 kboed (85% gas) for the nine months ended September 30, 2025. This aligns with full year guidance of 145-155 kboed (Key Developments).
- Production decreased year-over-year from 156 kboed to 151 kboed. The primary reason was the temporary suspension of production in Israel in June 2025 (Key Developments).
- Despite interruptions, Energean reaffirmed its 2025 full-year production guidance at 145-155 kboed (Key Developments).
- Energean was removed from the TA-35 index (Key Developments).
- Group output rose 35% to an average of 176 kboed in the third quarter of 2025 compared to 131 kboed in the second quarter (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has decreased slightly from $9.85 to $9.81.
- Discount Rate has risen slightly from 8.64% to 8.79%.
- Revenue Growth forecast has increased from 19.72% to 21.07%.
- Net Profit Margin estimate has grown from 16.65% to 18.64%.
- Future P/E ratio has decreased from 8.61x to 7.48x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.